Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 1, 2008, Pages 178-185

  Lima, Vivian C F ^a   Molchanov, Moriana L ^a   Aguiar, Daniele C ^a   Campos, Alline C ^a   Guimarães, Francisco Silveira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AIDA; Anxiety; Central gray; MPEP; Panic; tACPD

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 1 AMINO 1,5 INDANDICARBOXYLIC ACID; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; ANXIOLYTIC AGENT; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DEFENSIVENESS; LICKING; MALE; MAZE TEST; NEUROTRANSMISSION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; RAT; WISTAR RAT;

AGGRESSION; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGENTS; HINDLIMB SUSPENSION; MALE; MICROINJECTIONS; MOTOR ACTIVITY; PERIAQUEDUCTAL GRAY; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, AMPA; STATISTICS, NONPARAMETRIC;

EID: 38349052354     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.08.006     Document Type: Article

References (39)

1. Aguiar D.C., Moreira F.A., and Guimarães F.S. Flight reactions induced by injection of glutamate N-methyl-d-aspartate receptor agonist into the rat dorsolateral periaqueductal gray are not dependent on endogenous nitric oxide. Pharmacol Biochem Behav 83 (2006) 296-301
2. Albin R.L., Makowiec R.L., Hollingsworth Z., Dure L.St., Penney J.B., and Young A.B. Excitatory amino acid binding sites in the periaqueductal gray of the rat. Neurosci Lett 118 (1990) 112-115
3. Azkue J.J., Knöpfel T., Kuhn R., Mateos J.M., and Grandes P. Distribution of the metabotropic glutamate receptor subtype mGluR5 in rat periaqueductal grey and relationship with ascending spinofugal afferents. Neurosci Lett 228 (1997) 1-4
4. Ballard T.M., Woolley M.L., Prinssen E., Huwyler J., Porter R., and Spooren W. The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison. Psychopharmacology 179 (2005) 218-229
5. Bandler R., and Carrive P. Integrated defence reaction elicited by excitatory amino acid microinjection in the midbrain periaqueductal gray region of the unrestrained cat. Brain Res 439 (1988) 95-106
6. Berrino L., Oliva P., Rossi F., Palazzo E., Nobili B., and Maione S. Interaction between metabotropic and NMDA glutamate receptors in the periaqueductal grey pain modulatory system. Naunyn-Schmiedeberg's Arch Pharmacol 364 (2001) 437-443
7. Carobrez A.P., and Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29 (2005) 1193-1205
8. Carrive P. The periaqueductal gray and defensive behavior: functional representation and neuronal organization. Behav Brain Res 58 (1993) 27-47
9. de Novellis V., Marabese I., Palazzo E., Rossi F., Berrino L., Rodella L., et al. Group I metabotropic glutamate receptors modulate glutamate and gamma-aminobutyric acid release in the periaqueductal gray of rats. Eur Pharmacol 462 (2003) 73-81
10. Deakin J.F., and Graeff F.G. 5-HT and mechanisms of defense. J Psychopharmacol 5 (1991) 305-315
11. Drew G.M., and Vaughan C.W. Multiple metabotropic glutamate receptor subtypes modulate GABAergic neurotransmission in rat periaqueductal grey neurons in vitro. Neuropharmacology 46 (2004) 927-934
12. Ferraguti F., and Shigemoto R. Metabotropic glutamate receptors. Cell Tissue Res 326 (2006) 483-504
13. File S.E. Behavioural detection of anxiolytic action. In: Elliott J.M., Heal D.J., and Marsden C.A. (Eds). Experimental approaches to anxiety and depression (1992), Wiley, New York 25-44
14. Graeff F.G. Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals. Braz J Med Biol Res 27 (1994) 811-829
15. Guimarães F.S., Carobrez A.P., De Aguiar J.C., and Graeff F.G. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal gray. Psychopharmacology 103 (1991) 91-94
16. Heidinger V., Manzerra P., Wang X.Q., Strasser U., Yu S.P., Choi D.W., et al. Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons. J Neurosci 22 (2002) 5422-5461
17. Iijima M., and Chaki S. Separation-induced ultrasonic vocalization in rat pups: further pharmacological characterization. Pharmacol Biochem Behav 82 (2005) 652-657
18. Jardim M.C., Aguiar D.C., Moreira F.A., and Guimarães F.S. Role of glutamate ionotropic and benzodiazepine receptors in the ventromedial hypothalamic nucleus on anxiety. Pharmacol Biochem Behav 82 (2005) 182-189
19. Jenck F., Moreau J.L., and Martin J.R. Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity. Psychiatry Res 57 (1995) 181-191
20. Klodzinska A., Tatarczynska E., Stachowicz K., and Chojnacka-Wojcik E. The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist. J Physiol Pharmacol 55 (2004) 113-126
21. Krieger J.E., and Graeff F.G. Defensive behavior and hypertension induced by glutamate in the midbrain central gray of the rat. Braz J Med Biol Res 18 (1985) 61-67
22. Matheus M.G., and Guimarães F.S. Antagonism of non-NMDA receptors in the dorsal periaqueductal gray induces anxiolytic effect in the elevated plus maze. Psychopharmacology 132 (1997) 14-18
23. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 70 (2003) 83-244
24. Molchanov M.L., and Guimarães F.S. Defense reaction induced by a metabotropic glutamate receptor agonist microinjected into the dorsal periaqueductal gray of rats. Braz J Med Biol Res 32 (1999) 1533-1537
25. Molchanov M.L., and Guimarães F.S. Anxiolytic-like effects of AP7 injected into the dorsolateral or ventrolateral columns of the periaqueductal gray of rats. Psychopharmacology 160 (2002) 30-38
26. Moreira F.A., Aguiar D.C., and Guimarães F.S. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Prog Neuro-Psychopharmacol Biol Psychiatry 30 (2006) 1466-1471
27. Moroni F., Lombardi G., Thomsen C., Leonardi P., Attucci S., Peruginelli F., et al. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. J Pharmacol Exp Ther 281 (1997) 721-729
28. Ozawa S., Kamiya H., and Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 54 (1998) 581-618
29. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 3rd ed. (1997), Academic Press, San Diego
30. Perez de la Mora M., Lara-Garcia D., Jacobsen K.X., Vazquez-Garcia M., Crespo-Ramirez M., Flores-Gracia C., et al. Anxiolytic-like effects of the selective metabotropic glutamate receptor 5 antagonist MPEP after its intra-amygdaloid microinjection in three different non-conditioned rat models of anxiety. Eur J Neurosci 23 (2006) 2749-2759
31. Pietraszek M., Sukhanov I., Maciejak P., Szyndler J., Gravius A., Wislowska A., et al. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. Eur J Pharmacol 514 (2005) 25-34
32. Pilc A., Klodzinska A., Branski P., Nowak G., Palucha A., Szewczyk B., et al. Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats. Neuropharmacology 43 (2002) 181-187
33. Pin J.-P., and Duvoisin R. Review: neurotransmitter receptors I. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34 (1995) 1-26
34. Schenberg L.C., Bittencourt A.S., Sudre E.C., and Vargas L.C. Modeling panic attacks. Neurosci Biobehav Rev 25 (2001) 647-659
35. Schoepp D.D., Jane D.E., and Monn J.A. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38 (1999) 1431-1476
36. Spooren W., and Gasparini F. mGlu5 receptor antagonists: a novel class of anxiolytics?. Drug News Perspect 17 (2004) 251-257
37. Tatarczynska E., Klodzinska A., Chojnacka-Wojcik E., Palucha A., Gasparini F., Kuhn R., et al. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 132 (2001) 1423-1430
38. Tatarczynska E., Klodzinska A., Kroczka B., Chojnacka-Wojcik E., and Pilc A. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration. Psychopharmacology 158 (2001) 94-99
39. Varty G.B., Grilli M., Forlani A., Fredduzzi S., Grzelak M.E., Guthrie D.H., et al. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Psychopharmacology 179 (2005) 207-217